Factors affecting theophylline clearances: age, tobacco, marijuana, cirrhosis, congestive heart failure, obesity, oral contraceptives, benzodiazepines, barbiturates, and ethanol.
about
Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic reviewEstimation of pharmacokinetic parameters based on the patient-adjusted population data.Metabolism of theophylline by cDNA-expressed human cytochromes P-450.Effects of time of dosing and age on intravenous aminophylline pharmacokinetics.The accuracy of a pharmacokinetic theophylline predictor using once daily dosingDeterminants of free theophylline clearance in asthmaLack of effect of highly purified subunit influenza vaccination on theophylline metabolism.Caffeine disposition in obesity.Steady-state pharmacokinetics and effects of a new once-daily, slow-release theophylline capsule preparation in asthmaPharmacokinetics of theophylline: a dose-range study.Effects of tobacco smoking and oral contraceptive use on theophylline disposition.Polymorphism of theophylline metabolism in man.Population pharmacokinetics of theophylline during paediatric extracorporeal membrane oxygenation.Advocating for patients through clinical research.Application of a Physiologically Based Pharmacokinetic Model to Study Theophylline Metabolism and Its Interactions With Ciprofloxacin and Caffeine.Case Report: The risks associated with chronic theophylline therapy and measures designed to improve monitoring and management.Impact of obesity on drug metabolism and elimination in adults and children.Interspecies metabolism and pharmacokinetic scaling of theophylline disposition.The toxicology of cocoa and methylxanthines: a review of the literature.Pharmacokinetic Drug Interactions with Tobacco, Cannabinoids and Smoking Cessation Products.Massive theophylline dosing in a heavy smoker receiving both phenytoin and phenobarbital.Theophylline steady-state pharmacokinetics: recent concepts and their application in chronotherapy of reactive airway diseases.Inhibition of theophylline clearance by coadministered ofloxacin without alteration of theophylline effects.Pharmacogeriatrics.Drug metabolism in the elderly: confounding of age, smoking, and ethanol effects.Theophylline. A "state of the art" review.Influence of endotoxin-induced fever on the pharmacokinetics of theophylline in the rabbit model.Acute and chronic human toxicity of theophylline.The population pharmacokinetics of theophylline in neonates and young infants.Clinical pharmacokinetics: a comprehensive system for therapeutic drug monitoring and prescribingOPT: a package of computer programs for parameter optimisation in clinical pharmacokinetics.Verofylline pharmacokinetics in dietary-induced obese rats: role of fat mass and protein binding in determining volume of distribution.A Microcomputer Drug (Theophylline) Dosing Program Which Assists and Teaches Physicians.ASSIST: A Clinically Oriented Drug Level Forecasting System.Medical marijuana: Between a plant and a hard place.Evaluation of population (NONMEM) pharmacokinetic parameter estimates.Comment on kinetic predictions of serum drug concentrations.Comparison of two sustained-release theophylline preparations in adult patients with obstructive airways disease.Increased theophylline concentrations secondary to ciprofloxacin.
P2860
Q28300877-F4F2A1D6-0573-45B3-9AE1-59D224560D9FQ31082856-60E7C2E9-EA2C-4043-BE7D-FC0C4F462D2DQ34347072-497275F1-0083-490B-916E-FD4B030370DBQ34416760-75EFB506-1136-419E-A8B2-FDC4E8174C78Q34416820-CA9514D3-B412-409C-946F-CFD3F0E02A7EQ34417136-6C0F805F-DF37-410D-8752-8063F3E500DCQ34446520-489A752C-7A5F-47A5-8D4B-2096C146A9EBQ34446539-01DFA845-BA0B-4656-9905-BADD5925DC2FQ34448090-EF3BC11F-36BA-4A8D-B1E6-887963561380Q34511493-C35A18A8-C558-489E-A7B2-F54C5BC69F5EQ34513078-913C7243-A8D9-48ED-BA63-C70FFA234EC8Q34626564-9DE5C7B5-A33F-45E6-B2AF-96D4D787E21FQ35825168-B0ACD09C-1C07-437A-B810-B8CF1B50B2BDQ36290756-934D447B-0959-48FE-A532-A6E12369BCA0Q36600064-6C7DC915-8163-49EE-BADF-83E0CFD22C3AQ36654250-6F90DA44-966B-4FDF-B031-71C63D3A2521Q37997025-D576C704-27EF-4D99-A5C9-39E93E6EFABBQ38020763-FEEF5DEE-881B-4492-AEA5-6ED7F72653C2Q38580765-7A06C3CE-D4B7-450C-9BB5-C115AE6D9F6DQ38815352-3A7E2887-5882-4157-95F8-10C76005A085Q39503488-5368B9AC-AD4A-48BA-96DD-998C27748064Q39678145-0544B4C9-ED89-4499-ABE3-7C493722422DQ39827802-28BE3479-D183-432C-9390-8A141B809BA9Q39837842-1B7871F4-C9DC-44C0-83B6-7715659A51E7Q40147811-9876F851-F380-4F57-8D97-83FE5EDE60D0Q40150067-83DB9649-1C86-441C-8A5B-62AA588E0E73Q40779968-EA19904F-6D3E-4CCC-925D-3445497946C4Q41102634-523BF625-93F7-4165-AA96-F75A5D94A7DEQ41307855-92A0F322-2364-448D-98BF-4590D180B39BQ41902015-FE6519E2-045B-481F-89F2-EF7EFDC215EFQ43261718-9F341939-0FE9-4DDB-8FCB-467604C35015Q45107022-789DE6B9-E80C-44B0-AE5F-22BB3B0D394BQ45976347-9CEFAC5A-71E4-4493-8A59-B1052A29C37FQ46810228-E873409E-EC9E-4E54-968B-CC759AE3A1C7Q49979506-01404D5E-422E-4803-8BE8-DB0AEB9F81FFQ51736552-8A61702A-07B3-4A58-98B0-1D6CC7D7161FQ52702841-14B24919-750B-46B1-964A-69C12BE4C9F2Q53838236-1FB71A39-4D6D-4B32-900F-78F5A4D73C0CQ54397347-C6AE3020-7773-43BE-88B0-F72431ACE9D7
P2860
Factors affecting theophylline clearances: age, tobacco, marijuana, cirrhosis, congestive heart failure, obesity, oral contraceptives, benzodiazepines, barbiturates, and ethanol.
description
1979 nî lūn-bûn
@nan
1979年の論文
@ja
1979年論文
@yue
1979年論文
@zh-hant
1979年論文
@zh-hk
1979年論文
@zh-mo
1979年論文
@zh-tw
1979年论文
@wuu
1979年论文
@zh
1979年论文
@zh-cn
name
Factors affecting theophylline ...... es, barbiturates, and ethanol.
@en
Factors affecting theophylline ...... es, barbiturates, and ethanol.
@nl
type
label
Factors affecting theophylline ...... es, barbiturates, and ethanol.
@en
Factors affecting theophylline ...... es, barbiturates, and ethanol.
@nl
prefLabel
Factors affecting theophylline ...... es, barbiturates, and ethanol.
@en
Factors affecting theophylline ...... es, barbiturates, and ethanol.
@nl
P2093
P356
P1476
Factors affecting theophylline ...... es, barbiturates, and ethanol.
@en
P2093
P304
P356
10.1002/JPS.2600681106
P407
P577
1979-11-01T00:00:00Z